ZYUS Life Sciences (ZYUS) Financial Statements
ZYUS Life Sciences Financial Overview
ZYUS Life Sciences's market cap is currently $29.79M. The company's EPS TTM is ―; its P/E ratio is -1.52; ZYUS Life Sciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ― | ― | ― | ― | ― |
| Gross Profit | $ 171.00K | ― | $ -27.87K | $ 635.00 | $ -16.78K |
| Operating Income | $ -19.15M | $ -651.64K | $ -228.46K | $ -251.47K | $ -379.20K |
| EBITDA | $ -42.06M | $ -361.80K | $ 350.56K | $ -728.48K | $ 274.31K |
| Net Income | $ -42.59M | $ -361.80K | $ 350.56K | $ -728.48K | $ 274.31K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ― | ― | ― | ― | ― |
| Total Assets | $ 41.63M | $ 8.82M | $ 8.64M | $ 8.51M | $ 9.22M |
| Total Debt | $ 9.81M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ 3.95M | $ -6.95M | $ -8.59M | $ -8.45M | $ -9.15M |
| Total Liabilities | $ 18.51M | $ 202.54K | $ 96.23K | $ 318.69K | $ 299.71K |
| Stockholders' Equity | ― | ― | ― | ― | ― |
| Cash Flow | |||||
| Free Cash Flow | $ -18.29M | $ -193.35K | $ -333.35K | $ -21.68K | $ 15.29K |
| Operating Cash Flow | ― | ― | ― | ― | ― |
| Investing Cash Flow | ― | ― | ― | ― | ― |
| Financing Cash Flow | ― | ― | ― | ― | ― |
Currency in USD